News Conference News AHA 2024 ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS Michael O'Riordan November 21, 2024
News Conference News AHA 2023 MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia L.A. McKeown November 11, 2023
News Conference News AHA 2023 DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI Shelley Wood November 11, 2023
News Conference News AHA 2022 High-Sensitivity Troponin Testing on the Rise in the US but Still Limited Michael O'Riordan November 04, 2022
News Conference News AHA 2017 ‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18 Michael O'Riordan November 15, 2017
News Conference News AHA 2017 Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins Caitlin E. Cox November 14, 2017
News Conference News AHA 2017 Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation Michael O'Riordan November 13, 2017
News Conference News AHA 2017 Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many Todd Neale November 11, 2017
News Conference News AHA 2016 Chest Pain Clinic Reduces Emergency Department and Hospital ‘Frequent Fliers’ Michael O'Riordan November 21, 2016
News Conference News AHA 2016 PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests Yael L. Maxwell November 16, 2016
News Conference News AHA 2015 Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower Yael L. Maxwell November 08, 2015
News Conference News AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab November 13, 2011